Singulair - Asthma Treatment

views the best pictures

Asthma is a chronic disease of bronchial pathways through which the air enters and comes out of the lungs. The main symptoms are repetitive asphyxiation attacks and hissing respiration. The mortality rate due to asthma is relatively low compared to other chronic diseases.

Presently, over 300 thousand people suffer from asthma worldwide. Asthma is considered to be the most common disease among children. Asthma cannot be treated completely, however asthmatic symptoms may be managed.

Asthma treatment strongly depends on the asthma state. Two states are distinguished: the steady-state and the acute state characterized by asthma aggravation. During the asthmatic attack or acute state, it is necessary to cut it short using bronchospasmolytic preparations of different groups. Most frequently durting this are used the systemic adrenergic receptor stimulants (adrenaline, ephedrine) and of selective stimulants (berotec, salbutamol), as well as methylxanthines (eufillin, theophylline). At the same time, a person must receive mucolytic agents, massage, and respiratory gymnastics. In cases of active infection, it is recommended to take some antibiotics for a short period of time.

For long term treatment of asthma, inhalation hormones and leukotriene inhibitors (Singulair) are intended. The latter are used orally in form of tablets or chewable tablets to treat light-to-moderate course of asthma. Singulair is used to prevent asthma attacks in adults and children starting from the early age of 12 months old.

On any stage of asthma treatment, a patient has to be physically active following the exercise therapy, to keep strict diet avoiding allergenic products, and to be outdoors as much as possible to prevent new asthmatic attacks.